Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Videx
Active Ingredient(s): Didanosine 100mg
Dosage Form: Chewable/dispersible tablet
New Zealand Sponsor: Bristol-Myers Squibb (NZ) Limited
Manufacturer(s): Bristol-Myers Squibb Company, Evansville, Indiana, United States of America
Product: Videx
Active Ingredient(s): Didanosine 25mg
Dosage Form: Chewable/dispersible tablet
New Zealand Sponsor: Bristol-Myers Squibb (NZ) Limited
Manufacturer(s): Bristol-Myers Squibb Company, Evansville, Indiana, United States of America
Product: Videx
Active Ingredient(s): Didanosine 50mg
Dosage Form: Chewable/dispersible tablet
New Zealand Sponsor: Bristol-Myers Squibb (NZ) Limited
Manufacturer(s): Bristol-Myers Squibb Company, Evansville, Indiana, United States of America
Dated this 30th day of November 2000.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).